Skip to main content

Published locations for Migraine: Cardiovascular risk status does not influence safety and efficacy of ubrogepant

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Migraine: Cardiovascular risk status does not influence safety and efficacy of ubrogepant

User login

  • Reset your password
  • /content/migraine-cardiovascular-risk-status-does-not-influence-safety-and-efficacy-ubrogepant
  • /migraine-icymi/article/240137/headache-migraine/migraine-cardiovascular-risk-status-does-not